Primary Prevention ICD French Registry

The indication of implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death has been introduced later in France than in other parts of the World. Overall, we aimed to assess the risk-benefit ratio of this strategy over a 10 year period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Evaluation of Primary Prevention ICD in Real Life Death Death, Sudden Pathologic Processes Pathological Conditions, Signs and Symptoms Shock

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinique Pasteur

Toulouse, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Coronary artery disease or dilated cardiomyopathy with low ejection fraction implanted with an ICD in the setting of primary prevention (criteria at the discretion of the physician)

Exclusion criteria

Setting of secondary prevention
Other cardiopathies such as congenital, channelopathies, valvulopathies

Treatment and study plan

Primary outcomes

Incidences of Appropriate Therapies (ATP and Shocks) and ICD-Related Complications

Time frame: 3-year

Secondary outcomes

Cause-of-Death Analysis

Time frame: 3-year

Sponsors and collaborators

Lead sponsor

Clinique Pasteur

Other

Collaborators

Central Hospital, Nancy, France
Centre Cardiologique du Nord, St Denis
Clinique Pasteur Toulouse
European Georges Pompidou Hospital
Hopital Antoine Beclere, Clamart
Nouvelles Cliniques Nantaises, Nantes
Rennes University Hospital
University Hospital, Bordeaux
University Hospital, Grenoble
University Hospital, Lille
University Hospital, Marseille
University Hospital, Tours

Registry information

Official study title

Observatoire Multicentrique Français Des Porteurs de Défibrillateur Automatique Implantable en Prévention Primaire (Cardiopathie Ischémique ou Cardiomyopathie Dilatée)

Acronym: DAI-PP

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Nov 25, 2013
Registry last updated: Nov 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed